JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 7,040.00
-40.00 (-0.56%)
Jul 25, 2025, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 252.44 billion as of July 25, 2025. Its market cap has decreased by -9.33% in one year.
Market Cap
252.44B
Enterprise Value
353.34B
Revenue
67.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,040.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 252.44B, an increase of 95.53%. That is a compound annual growth rate of 12.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 252.44B | -8.97% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | 402.27B | 139.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.87T |
| Celltrion | 39.24T |
| ALTEOGEN | 24.69T |
| Yuhan | 9,152.41B |
| SK Biopharmaceuticals | 8,034.94B |
| Peptron | 6,663.04B |
| HLB Co., Ltd. | 6,558.63B |
| PharmaResearch | 5,797.42B |